Buspirone treatment of anxious alcoholics. A placebo-controlled trial.

No abstract is available for this paper.

• Publication year

  1994

• Venue

  Archives of General Psychiatry

• Publication date

  1994-09-01

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1001/ARCHPSYC.1994.03950090052008PMID 8080349
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Validity of the Distinction Between “Substance‐Induced” and “Independent” Depression and Anxiety Disorders

  1995cited by this paper
• The efficacy of fluvoxamine in obsessive-compulsive disorder: effects of comorbid chronic tic disorder.

  1993cited by this paper
• Involvement of the serotonergic system in ethanol intake in the rat.

  1993cited by this paper
• Serotonergic and dopaminergic involvement in ethanol intake.

  1992cited by this paper
• A placebo-controlled trial of buspirone in anxious inpatient alcoholics.

  1992cited by this paper
• The Structured Clinical Interview for DSM-III-R (SCID). I: History, rationale, and description.

  1992cited by this paper
• Effects of gepirone on ethanol consumption, exploratory behavior, and motor performance in rats

  1992cited by this paper
• Treatment of Comorbid Deneralized Anxiety in a Recently Detoxified Alcoholic Population with a Selective Serotonergie Drug (Buspirone)

  1992cited by this paper
• Effects of 5-HT-1A receptor agonists on ethanol preference in the rat.

  1992cited by this paper
• Effect of fluoxetine on alcohol consumption in male alcoholics.

  1992cited by this paper
• Treatment of comorbid generalized anxiety in a recently detoxified alcoholic population with a selective serotonergic drug (buspirone).

  1992cited by this paper
• Validity of the Computerized DIS for Diagnosing Psychiatric Inpatients

  1991cited by this paper
• Changes in anxiety among abstinent male alcoholics.

  1991cited by this paper
• Symptoms of anxiety in inpatient alcoholics with and without DSM-III-R anxiety diagnoses.

  1991cited by this paper
• Fluoxetine differentially alters alcohol intake and other consummatory behaviors in problem drinkers

  1990cited by this paper
• Anxiety disorders coexisting with substance dependence: treatment with buspirone

  1990cited by this paper
• Abuse Potential of Buspirone and Related Drugs

  1990cited by this paper
• Differential effects of viqualine on alcohol intake and other consummatory behaviors

  1989cited by this paper
• Serotonin and alcohol: interrelationships.

  1989cited by this paper
• Buspirone in the treatment of alcoholic patients.

  1989cited by this paper
• Serotonin uptake blockers and the treatment of alcoholism.

  1989cited by this paper
• Efficacy of fluvoxamine in obsessive-compulsive disorder. A double-blind comparison with placebo.

  1989cited by this paper
• An open trial of buspirone in alcoholics.

  1989cited by this paper
• Computerized administration of the Diagnostic Interview Schedule.

  1988cited by this paper
• The prevalence of psychiatric disorders in patients with alcohol and other drug problems.

  1988cited by this paper
• Serotonergic responsivity in obsessive-compulsive disorder. Effects of chronic clomipramine treatment.

  1988cited by this paper
• Anxiety and depression in substance abuse: clinical implications.

  1988cited by this paper
• Buspirone alters alcohol drinking induced in rats by tetrahydropapaveroline injected into brain monoaminergic pathways.

  1988cited by this paper
• Abuse liability and clinical pharmacokinetics of alprazolam in alcoholic men.

  1988cited by this paper
• The co-occurrence of alcoholism with other psychiatric disorders in the general population and its impact on treatment.

  1988cited by this paper
• Serotonin function in obsessive-compulsive disorder. A comparison of the effects of tryptophan and m-chlorophenylpiperazine in patients and healthy subjects.

  1988cited by this paper
• Animal models of anxiety: the effect of compounds that modify 5-HT neurotransmission

  1987cited by this paper
• Serotonin function in anxiety

  1987cited by this paper
• Buspirone attenuates volitional alcohol intake in the chronically drinking monkey.

  1987cited by this paper
• The serotonin uptake inhibitor citalopram attenuates ethanol intake

  1987cited by this paper
• Alcohol use and abuse among diagnosed agoraphobics.

  1986cited by this paper
• Anxiolytics and the alcoholic patient.

  1986cited by this paper
• Investigation of the abuse liability of buspirone in alcohol-dependent patients.

  1986cited by this paper
• Modulation of ethanol intake by serotonin uptake inhibitors.

  1986cited by this paper
• The dexamethasone suppression test and response to somatic treatment: a review.

  1986cited by this paper
• Recent developments in 5HT-related pharmacology of animal models of anxiety.

  1986cited by this paper
• Psychopathology in hospitalized alcoholics.

  1985cited by this paper
• Pharmacological and clinical effects of buspirone.

  1985cited by this paper
• The clinical implications of primary diagnostic groups among alcoholics.

  1985cited by this paper
• Hyperventilation, anxiety, craving for alcohol: a subacute alcohol withdrawal syndrome.

  1985cited by this paper
• Relapse by alcohol abusers.

  1985cited by this paper
• Comparison of diazepam and oxazepam: preference, liking and extent of abuse.

  1984cited by this paper
• Zimelidine‐induced variations in alcohol intake by nondepressed heavy drinkers

  1984cited by this paper
• Clinical studies of buspirone.

  1984cited by this paper
• "Never believe an alcoholic"? On the validity of self-report measures of alcohol dependence and related constructs.

  1983cited by this paper
• Abuse potential of halazepam and of diazepam in patients recently treated for acute alcohol withdrawal

  1983cited by this paper
• Effects of alcohol on buspirone and lorazepam actions

  1982cited by this paper
• Assessment of the abuse liability of buspirone in recreational sedative users.

  1982cited by this paper
• Pharmacology and neurochemistry of buspirone.

  1982cited by this paper
• Acute effects of buspirone and alcohol on psychomotor skills.

  1982cited by this paper
• Buspirone and diazepam in anxiety: a controlled study.

  1982cited by this paper
• A double-blind comparison of buspirone and diazepam in outpatients with generalized anxiety disorder.

  1982cited by this paper
• DSM-III Case Book: A Learning Companion to the Diagnostic and Statistical Manual of Mental Disorders (Third Edition)

  1981cited by this paper
• Developing a Prototype for Evaluating Alcohol Treatment Effectiveness

  1980cited by this paper
• Persistence of a "subacute withdrawal syndrome" following chronic ethanol intake.

  1979cited by this paper
• Alcohol and central serotonin metabolism in man.

  1979cited by this paper
• THE USE OF PSYCHOACTIVE DRUGS IN THE LONG‐TERM TREATMENT OF CHRONIC ALCOHOLICS

  1975cited by this paper
• Phobic anxiety syndrome complicated by drug dependence and addiction. A treatable form of drug abuse.

  1972cited by this paper
• An experimental analysis of the behavior of alcoholics and nonalcoholics during prolonged experimental drinking: A necessary precursor of behavior therapy?

  1971cited by this paper
• The Michigan alcoholism screening test: the quest for a new diagnostic instrument.

  1971cited by this paper
• An inventory for measuring depression.

  1961cited by this paper
• The assessment of anxiety states by rating.

  1959cited by this paper
• Tests of certain linear hypotheses and their application to some educational problems.

  1936cited by this paper

• Bridging Genomics and Pharmacoepidemiology to Expand Treatment Options for Alcohol Use Disorder

  2026cites this paper
• Efficacy and Safety of Psychoactive Tryptamines in Addiction: A Systematic Review

  2025cites this paper
• EFFICACY OF MEDICATIONS FOR THE TREATMENT OF ALCOHOL USE DISORDER (AUD): A SYSTEMATIC REVIEW AND META-ANALYSIS CONSIDERING BASELINE AUD SEVERITY.

  2024cites this paper
• Can Buspirone be a Remedy for an SSRI / SNRI-induced Bruxism? (tur)

  2021cites this paper
• Efficacy of pharmacotherapeutics for patients comorbid with alcohol use disorders and depressive symptoms—A bayesian network meta‐analysis

  2020cites this paper
• Therapeutic Strategies in Alcohol and Tobacco Addiction

  2020cites this paper
• The role of serotonin in alcohol use and abuse

  2020cites this paper
• Therapeutische Strategien bei Alkohol- und Tabakabhängigkeit

  2020cites this paper
• Treatment for Substance Use Disorder With Co-Occurring Mental Illness.

  2019cites this paper
• Advancing Pharmacotherapy Development from Preclinical Animal Studies.

  2018cites this paper
• Symptomatic and Syndromal Levels of Enquiry in the Anxiety – Alcohol Relationship

  2017cites this paper
• Current Treatment Options for Co-Morbid Anxiety and Alcohol Use Disorders: A Review

  2017cites this paper
• Treatment of Comorbid Alcohol Dependence and Anxiety Disorder: Review of the Scientific Evidence and Recommendations for Treatment

  2017influential citation
• Pharmacotherapies for Cannabis Use Disorders

  2017cites this paper
• Guidelines of the Brazilian Association of Studies on Alcohol and Other Drugs (ABEAD) for diagnosis and treatment of psychiatric comorbidity with alcohol and other substance and dependence

  2017cites this paper
• The antihypertensive drug pindolol attenuates long‐term but not short‐term binge‐like ethanol consumption in mice

  2017cites this paper
• The Psychopharmacology Algorithm Project at the Harvard South Shore Program: An Algorithm for Generalized Anxiety Disorder.

  2016cites this paper
• Treatment of Cannabis Use Disorder: Current Science and Future Outlook

  2016cites this paper
• Guidelines on the management of co-occurring alcohol and other drug and mental health conditions in alcohol and other drug treatment settings.

  2016cites this paper
• Contribution of Noradrenaline, Serotonin, and the Basolateral Amygdala to Alcohol Addiction: Implications for Novel Pharmacotherapies for AUDs

  2016cites this paper
• Pharmacotherapy for anxiety and comorbid alcohol use disorders.

  2015cites this paper
• A review on alcohol: from the central action mechanism to chemical dependency.

  2015cites this paper
• The role of serotonin in drug use and addiction.

  2015cites this paper
• Serotonergic Neuroplasticity in Alcohol Addiction

  2015cites this paper
• Serotonergic Systems in the Pathophysiology of Ethanol Dependence: Relevance to Clinical Alcoholism.

  2015cites this paper
• Substance‐Related Disorders: Alcohol‐Related Disorders

  2015cites this paper
• Comorbidity in detoxification: symptom interaction and treatment intentions.

  2015cites this paper
• Pharmacologic treatment of alcoholism.

  2014cites this paper
• Dopamine D3 receptor ligands for drug addiction treatment: update on recent findings.

  2014cites this paper
• JOURNAL OF ADDICTIVE DISORDERS An Overview of the Relapse Prevention ( RP ) Model

  2014cites this paper
• Pharmacotherapy of alcohol use disorders: seventy-five years of progress.

  2014cites this paper
• Alkol ve Madde Bağimliliğinda Remisyon ve Depreşme Remission and Relapse in Alcohol and Substance Addiction

  2014cites this paper
• Alcohol algorithm: 09/18/13 Alcohol Algorithm

  2013cites this paper
• [Pharmacotherapy and psychotherapy of comorbid anxiety disorders and alcoholism].

  2013cites this paper
• Interactions of a Dopamine D1 Receptor Agonist with Glutamate NMDA Receptor Antagonists on the Volitional Consumption of Ethanol by the mHEP Rat

  2013cites this paper
• One person , diverse needs : living with mental health and alcohol and drug difficulties

  2013cites this paper
• Amygdaloid Corticotropin-releasing Factor is Involved in the Anxiolytic Effect of Acupuncture during Ethanol Withdrawal in Rats

  2013cites this paper
• Pharmacological Treatment of Alcohol Dependence

  2013cites this paper
• Substance Use Disorders and Anxiety: A Treatment Challenge for Social Workers

  2013cites this paper
• Basic Treatment Techniques for Persons with Mental Disorders and Co-occurring Substance Use Disorders

  2012cites this paper
• Pharmacotherapy of Alcoholism in Patients with Co-morbid Psychiatric Disorders

  2012cites this paper
• Comorbid Anxiety and Substance Use Disorders

  2012cites this paper
• Pharmacotherapy of Alcohol Use Disorders and Concurrent Psychiatric Disorders: A Review

  2012cites this paper
• The Relationship of Appetitive, Reproductive and Posterior Pituitary Hormones to Alcoholism and Craving in Humans

  2012cites this paper
• Different addictive drug exposure induces selective alterations of the Endogenous Opioid System : modulation of transcription and epigenetic mechanisms

  2012cites this paper
• BAP updated guidelines: evidence-based guidelines for the pharmacological management of substance abuse, harmful use, addiction and comorbidity: recommendations from BAP

  2012cites this paper
• Treatment of substance abusing patients with comorbid psychiatric disorders.

  2012cites this paper
• Anxiety and Alcohol Use Disorders

  2012cites this paper
• Evaluation of buspirone for relapse-prevention in adults with cocaine dependence: an efficacy trial conducted in the real world.

  2012cites this paper
• Understanding and treating comorbid anxiety disorders in substance users: review and future directions.

  2011cites this paper
• Psychopharmacological Treatment of Anxiety in Adolescents with Comorbid Substance Abuse

  2011cites this paper
• Gender differences in outcome at 2-year follow-up of treated bipolar and depressed alcoholics.

  2011cites this paper
• Integrating Care for People With Co-Occurring Alcohol and Other Drug, Medical, and Mental Health Conditions

  2011cites this paper
• Meta-analysis of supplemental treatment for depressive and anxiety disorders in patients being treated for alcohol dependence.

  2011cites this paper
• Lesch Alcoholism Typology Medical Treatment and Research

  2010cites this paper
• In Memory of Dora Kohen

  2010cites this paper
• Unhealthy Alcohol and Drug Use in Primary Care

  2010cites this paper
• Medications acting on the serotonergic system for the treatment of alcohol dependent patients.

  2010cites this paper
• Chapter 5 Management of comorbidity

  2009cites this paper
• A double-blind, placebo-controlled study of sertraline with naltrexone for alcohol dependence.

  2009cites this paper
• An Open-Label Trial of Aripiprazole Treatment in Dual Diagnosis Individuals: Safety and Efficacy

  2009influential citation
• Cognitive-behavioral therapy for panic disorder in patients being treated for alcohol dependence: Moderating effects of alcohol outcome expectancies.

  2009cites this paper
• Aripiprazole in the treatment of patients with alcohol dependence: a double-blind, comparison trial vs. Naltrexone

  2009cites this paper
• How Adaptation of the Brain to Alcohol Leads to Dependence

  2008cites this paper
• How Adaptation of the Brain to Alcohol Leads to Dependence

  2008cites this paper
• Medical Management of Co-Morbid Anxiety and Substance Use Disorder

  2008cites this paper
• Anxiety and substance use: layers of complexity

  2008cites this paper
• Anxiety and Substance Use Disorders: A Review.

  2008cites this paper
• Levetiracetam for the Treatment of Co-Occurring Alcohol Dependence and Anxiety: Case Series and Review

  2008cites this paper
• Anxiety Disorders with Comorbid Substance Use Disorders: Diagnostic and Treatment Considerations.

  2008cites this paper
• Alcohol Use and Anxiety Disorders

  2008cites this paper
• Anxiety Disorder and Substance Use Disorder Co-Morbidity: Common Themes and Future Directions

  2008cites this paper
• Stress, Anxiety, and Addiction

  2007cites this paper
• Treatments for patients with dual diagnosis: a review.

  2007cites this paper
• Verslaving en persoonlijkheidspathologie

  2007cites this paper
• Preclinical and clinical pharmacology of alcohol dependence

  2007cites this paper
• Effects of atypical anxiolytic N-phenyl-2-[1-[3-(2-pyridinylethynyl)benzoyl]-4-piperidine]acetamide (JNJ-5234801) on alcohol intake in alcohol-preferring P rats.

  2007cites this paper
• Chapitre 12 – Éthanol

  2007cites this paper
• Therapeutic options and challenges for substances of abuse

  2007cites this paper
• Alcohol use and anxiety: diagnostic and management issues.

  2007cites this paper
• Alcoholism and suicidal behavior: a clinical overview

  2006cites this paper
• Editorial Review: Current Review of the Comorbidity of Affective, Anxiety, and Substance Use Disorders

  2006cites this paper
• [Guidelines of the Brazilian Association of Studies on Alcohol and Other Drugs (ABEAD) for diagnoses and treatment of psychiatric comorbidity with alcohol and other drugs dependence].

  2006cites this paper
• Pharmacotherapeutic Interventions to Maintaining Abstinence in Alcoholism

  2006cites this paper
• Suchttherapeutika zur Sucht

  2006cites this paper
• Diretrizes da Associação Brasileira de Estudos do Álcool e outras Drogas (ABEAD) para o diagnóstico e tratamento de comorbidades psiquiátricas e dependência de álcool e outras substâncias

  2006cites this paper
• Tests of a symptom checklist to screen for comorbid psychiatric disorders in alcoholism.

  2006cites this paper
• Literature review of interventions to reduce the burden of harm from tobacco smoking, poor nutrition, alcohol misuse and physical inactivity.

  2005cites this paper
• Follow-up study of anxiety disorder and alcohol dependence in comorbid alcoholism treatment patients.

  2005cites this paper
• Patient‐treatment matching with anti‐craving medications in alcohol‐dependent patients: A review on phenotypic, endophenotypic and genetic indicators

  2005cites this paper
• Etiological Theories on the Relationship of Mental Disorders and Substance Use Disorders

  2005cites this paper
• Long-term use of benzodiazepines in participants with comorbid anxiety and alcohol use disorders.

  2005cites this paper
• Serotonergic compounds: clinical data

  2005cites this paper
• Clinical practice. Unhealthy alcohol use.

  2005cites this paper
• How to measure relapse in humans

  2005cites this paper
• New achievements and pharmacotherapeutic approaches in the treatment of alcohol dependence.

  2005cites this paper
• Pharmacotherapy of Comorbid Mood, Anxiety, and Substance Use Disorders

  2005cites this paper
• Pharmacotherapy of Alcohol Use Disorders

  2005cites this paper
• Evidence-based treatment: why, what, where, when, and how?

  2005cites this paper
• Comorbid Anxiety and Substance Use Disorders

  2005cites this paper